EP13: Unveiling Drug Ad Secrets: Gender Bias, Influencer Marketing, & New FDA Regulations You Need to Know for Informed Health Choices!

Ever wondered how drug ads subtly shape your health perceptions? We dives deep into the striking female bias in U.S. antidepressant advertising and how weight-loss drugs strategically employ "patient influencers" on social media. We'll also explore the FDA's recent stringent crackdown on misleading drug ads, specifically addressing the "adequate provision" loophole that minimized risk disclosure. Empower yourself with this knowledge to become a savvier, more discerning health decision-maker, free from deceptive promotions! References: 1.The FDA’s Overdue Crackdown on Misleading Pharmaceutical Advertisements. 2.FDA Cracks Down on Deceptive Prescription Drug Advertising. 3.Crackdown on Deceptive Weight Loss Drug Ads Marks Victory for Consumers. 4.Gender bias in antidepressant direct-to-consumer pharmaceutical advertising. 5.Critical discourse analysis of social media advertisements for GLP-1 receptor agonist weight loss drugs: implications for public perceptions and health communication. 6.Communicating Health Literacy on Prescription Medications on Social Media: In-depth Interviews With “Patient Influencers”. 7.Pharmaceutical industry promotional activities on social media: a scoping review -- Hosting provided by SoundOn